Clinical Services > Pharmacy

Bill to shore up medicine supplies: SHPA

03 December, 2021

The Society of Hospital Pharmacists of Australia (SHPA) has welcomed new federal government legislation to further mitigate the impact of medicine shortages on Australians and ensure new and innovative medicines are accessible, available and affordable.


More expert pharmacists needed in the era of medicine miracles

23 September, 2021 by Kristin Michaels, SHPA Chief Executive

As we live through the lengthening tail of a persistent pandemic, it is challenging to consider the simpler medicines landscape of 20 years ago.


Aus antimicrobial use decreasing but not enough: report

27 August, 2021

While antimicrobial use in the community is decreasing, overprescribing and inappropriate prescribing continue to be problematic.


Review of National Medicines Policy after 22 years

04 August, 2021

For the first time since its development in 1999, Australia's National Medicines Policy is set for review.


Speed up pharmacy vaccine rollout to end lockdown, says report

21 July, 2021

Accelerating the rollout of vaccines into pharmacies could help Australia reach its vaccination target of 80% up to two months faster than current projections.


Medicinal cannabis facility planned for Toowoomba

12 July, 2021

Medibis has announced long-term plans to build a multi-million-dollar medicinal cannabis facility in Toowoomba, Queensland.


Metabolic hormone leptin linked to vaccine response

31 May, 2021 by Amy Sarcevic

Reduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.


New COVID-19 vaccine completely blocks viral transmission

19 May, 2021 by Amy Sarcevic

An Adelaide-based company has developed a COVID-19 vaccine that completely blocks viral transmission to individuals who lack immunity, as well as offering protection for those inoculated.


Historic PBS listing of cannabis for Dravet syndrome

10 May, 2021

Epidyolex has been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy.


New national standard for intensive care pharmacists

05 May, 2021

The standardised guidelines place pharmacists as key members of the multidisciplinary medical team caring for patients in the ICU.


Evidence urgently needed on how to safely withdraw patients from antidepressants

03 May, 2021 by Amy Sarcevic

Researchers at the Cochrane Collaboration reviewed 33 studies involving nearly 5000 participants, relating to antidepressant discontinuation.


Putting pharmacists where they're needed most

27 April, 2021 by Kristin Michaels, SHPA CEO

SHPA will continue to advocate for investment in embedding geriatric medicine pharmacists as part of clinical pharmacy services for aged-care residents.


The collaboration igniting malaria drug discovery

27 April, 2021

Johnson & Johnson Innovation has facilitated a collaboration between WEHI and Janssen Pharmaceutica NV to ignite the development of antimalarial drug candidates.


AstraZeneca vaccine myths debunked

14 April, 2021 by Amy Sarcevic

Australians are being reminded that a causal relationship between blood clotting and adenovirus vector-based vaccines has still not been established, and that — should it be — the risk remains far lower than that of common medications.


New cell-based flu vaccine to be rolled out this month

07 April, 2021 by Amy Sarcevic

This winter, for the first time, a new cell-based flu vaccine will be introduced in Australia, in a bid to boost the efficacy rates of national immunisation programs.


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd